Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05963906 · ClinicalTrials.gov registry record
Food Survey, Curbside, Remote APPs SCFI
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 57
- Enrollment target
NCT05963906: Completed study, sponsored by Pennington Biomedical Research Center.
NCT05963906 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05963906 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
The proposed research will create accurate and standardized household food waste measurement technologies that foster serial and longitudinal assessments as well as confident and convenient one-time measurement. The investigators propose the SCFI field study where participants simultaneously deploy 3 measurement approaches (1) retrospective surveys (2) curbside audits, and (3) the FoodImage smartphone app.
Primary Outcome
Weight
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2023-10-10 |
| Est. Completion | 2024-11-19 |
What the finished NCT05963906 record still lists
NCT05963906 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05963906 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05963906 about?
NCT05963906 is a clinical study titled "Food Survey, Curbside, Remote APPs SCFI". The proposed research will create accurate and standardized household food waste measurement technologies that foster serial and longitudinal assessments as well as confident and convenient one-time measurement. The investigators propose the SCFI field study where participants simultaneously deploy ...
What is the current status of trial NCT05963906?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2023-10-10. Estimated completion is 2024-11-19.
Who is sponsoring clinical trial NCT05963906?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI